Disclosed herein, in certain instances, are methods of inhibiting osteoclast differentiation, bone resorption, bone formation, and bone remodeling in an individual in need thereof, comprising administering to the individual a composition comprising substantially fetal support tissue product includin
Disclosed herein, in certain instances, are methods of inhibiting osteoclast differentiation, bone resorption, bone formation, and bone remodeling in an individual in need thereof, comprising administering to the individual a composition comprising substantially fetal support tissue product including amniotic membrane and umbilical cord or an extract thereof, or a composition comprising substantially isolated HC-HA complex.
대표청구항▼
1. A method of promoting or inducing osteogenesis in an individual in need thereof, comprising contacting a bone or joint in the individual with a therapeutically-effective amount of a fetal support tissue that comprises: (a) cells, substantially all of which are dead, and (b) HC-HA; thereby promoti
1. A method of promoting or inducing osteogenesis in an individual in need thereof, comprising contacting a bone or joint in the individual with a therapeutically-effective amount of a fetal support tissue that comprises: (a) cells, substantially all of which are dead, and (b) HC-HA; thereby promoting or inducing osteogenesis in the individual. 2. The method of claim 1, wherein the fetal support tissue is placental amniotic membrane (PAM), umbilical cord amniotic membrane (UCAM), placenta, umbilical cord, chorion, amnion-chorion, or combinations thereof. 3. The method of claim 1, wherein the fetal support tissue is frozen or previously frozen. 4. The method of claim 1, wherein the fetal support tissue is a sheet, a powder, or a homogenate. 5. The method of claim 1, wherein the fetal support tissue is cryopreserved, lyophilized, terminally sterilized, or a combination thereof. 6. The method of claim 1, wherein contacting the joint with the fetal support tissue comprises injecting the fetal support tissue into the joint. 7. The method of claim 1, wherein contacting the bone or joint with the fetal support tissue comprises wrapping a fetal support tissue sheet around the bone or joint. 8. The method of claim 1, wherein the individual in need thereof has arthritis, osteoporosis, a bone tumor, Paget's Disease, alveolar bone degradation, or any combination thereof. 9. The method of claim 1, wherein contacting the bone or joint with the fetal support tissue comprises contacting the bone or joint with a medical device comprising the fetal support tissue. 10. The method of claim 9, wherein the medical device is a patch, implant, orthopedic prosthesis, or bone stent.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (75)
Lee Ping I. (Berwyn PA), Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentrati.
Urquhart John (Palo Alto CA) Chandrasekaran Santosh Kumar (Palo Alto CA) Shaw Jane Elizabeth (Atherton CA), Bandage for transdermally administering scopolamine to prevent nausea.
Kris P. Antonsen ; Rajiv Nayar ; Wei Wang ; Margaret Caudle ; Michael A. Shearer ; Neville M. Concessio, Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations.
Dansereau Richard J. (Sherburne NY) Mosher Russell Y. (Norwich NY) Axelrod Douglas W. (Norwich NY) Sietsema William K. (Norwich NY), Dosage forms of risedronate.
Brown Karen K. (Kansas City MO) Greene Nathan D. (Leawood KS) Trump Sandy L. (DeSoto KS) Bryant Sharon A. (Shawnee KS), Low viscosity high molecular weight filter sterilizable hyaluronic acid.
Chandrasekaran Santosh Kumar (Palo Alto CA) Urquhart John (Palo Alto CA) Shaw Jane Elizabeth (Atherton CA), Method and therapeutic system for providing chemotherapy transdermally.
Tayot Jean-Louis (La Tour de Salvagny FRX) Tardy Michel (Lyons FRX), New preparation of placenta collagen, their extraction method and their applications.
Radebaugh Galen W. (Maple Glen PA) Murtha John L. (Holland PA) Glinecke Robert (Glenside PA), Oral sustained release acetaminophen formulation and process.
Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH), Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery.
Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Yamashita Gentaro (Koganei JPX), Slow-releasing medical preparation to be administered by adhering to a wet mucous surface.
Phillips Richard E. (San Marcos TX) Moore Mark A. (Austin TX) Russell Ruth L. (Long Beach CA) Cheung David (Arcadia CA), Sterilization of tissue implants using iodine.
Chandrasekaran Santosh K. (Palo Alto CA) Darda Siegfried (Ingelheim am Rhein CA DEX) Michaels Alan S. (Atherton CA) Cleary Gary W. (Palo Alto CA), Therapeutic system for administering clonidine transdermally.
Davis Roosevelt (27 Lullwater Estate Rd. Atlanta GA 30307) Primo-Davis Susan A. (27 Lullwater Estate Rd. Atlanta GA 30307), Transdermal therapeutic formulation.
Milan Adam,CZX ; Eggersgluss Bernd,DEX ; Braumer Klaus,DEX ; Schrieber Reinhard,DEX, Use of tasteless, hydrolyzed collagen and agent containing the same.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.